A little more than 8 months after jumping out of stealth mode with a $32 million venture round and a game plan to develop new antifungals, Cidara Therapeutics CEO Jeff Stein is jumping into the queue for Nasdaq with an IPO designed to raise $69 million.

…read more

Source: Cidara Therapeutics makes a quick leap into the growing Q1 IPO queue


0 No comments